Cargando…
Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma
SIMPLE SUMMARY: Adenoid cystic carcinoma (ACC) is a rare cancer of the head and neck. Initial treatment may involve surgery and/or radiotherapy with the aim of removing the cancer and preventing spread to other parts of the body. In patients in whom ACC has recurred or spread, systemic therapies suc...
Autores principales: | Feeney, Laura, Jain, Yatin, Beasley, Matthew, Donnelly, Oliver, Kong, Anthony, Moleron, Rafael, Nallathambi, Chandran, Rolles, Martin, Sanghera, Paul, Tin, Aung, Ulahannan, Danny, Walter, Harriet S., Webster, Richard, Metcalf, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431195/ https://www.ncbi.nlm.nih.gov/pubmed/34503145 http://dx.doi.org/10.3390/cancers13174336 |
Ejemplares similares
-
The Centralisation of Energy
por: Wooton, Edwin
Publicado: (1880) -
Inconsistent centralised versus non-centralised ischaemic stroke aetiology
por: Suo, Yue, et al.
Publicado: (2020) -
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy
por: Kuroda, Hidekatsu, et al.
Publicado: (2022) -
RECIST rules
por: Sohaib, Aslam
Publicado: (2012) -
Hospital Centralisation at Aberdeen
Publicado: (1887)